Pinebridge Investments L.P. Has $15.60 Million Stake in DaVita Inc. (NYSE:DVA)

Pinebridge Investments L.P. cut its holdings in DaVita Inc. (NYSE:DVA - Free Report) by 6.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 104,294 shares of the company's stock after selling 7,622 shares during the period. Pinebridge Investments L.P. owned approximately 0.13% of DaVita worth $15,597,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. SBI Securities Co. Ltd. bought a new stake in DaVita in the fourth quarter worth $41,000. Canada Post Corp Registered Pension Plan acquired a new stake in shares of DaVita in the fourth quarter valued at about $55,000. Venturi Wealth Management LLC increased its stake in shares of DaVita by 59.8% in the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock worth $61,000 after purchasing an additional 152 shares during the period. Versant Capital Management Inc increased its stake in shares of DaVita by 58.7% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $68,000 after purchasing an additional 169 shares during the period. Finally, Blue Trust Inc. lifted its position in shares of DaVita by 39.7% during the 4th quarter. Blue Trust Inc. now owns 461 shares of the company's stock worth $76,000 after purchasing an additional 131 shares during the last quarter. 90.12% of the stock is currently owned by institutional investors.

DaVita Stock Performance

Shares of NYSE:DVA traded up $1.11 during trading on Tuesday, hitting $141.61. 207,993 shares of the stock were exchanged, compared to its average volume of 838,228. DaVita Inc. has a 1-year low of $131.27 and a 1-year high of $179.60. The company has a market capitalization of $11.33 billion, a price-to-earnings ratio of 13.19, a price-to-earnings-growth ratio of 1.07 and a beta of 1.04. The company's fifty day simple moving average is $146.22 and its 200-day simple moving average is $155.10. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26.

DaVita (NYSE:DVA - Get Free Report) last announced its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. Sell-side analysts expect that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Analysts Set New Price Targets

Several brokerages have commented on DVA. Barclays lifted their price target on DaVita from $164.00 to $169.00 and gave the stock an "equal weight" rating in a research report on Tuesday, February 18th. StockNews.com raised DaVita from a "hold" rating to a "buy" rating in a research report on Friday. Sanford C. Bernstein set a $184.00 price target on DaVita in a research report on Friday, February 21st. Finally, Cowen reaffirmed a "hold" rating on shares of DaVita in a research report on Tuesday, February 18th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $166.33.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.